B. Vanneste

发表

Development and Internal Validation of a Novel Nomogram Predicting the Outcome of Salvage Radiation Therapy for Biochemical Recurrence after Radical Prostatectomy in Patients without Metastases on Restaging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography

M. Heymans, M. Donswijk, A. Lont, 2024, European urology open science.

Radiation Oncology Orals

M. Ruschin, J. Detsky, A. Steigler, 2023, Journal of Medical Imaging and Radiation Oncology.

Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial.

B. Higgs, F. Foroudi, R. De Abreu Lourenço, 2024, The Lancet. Oncology.

TROG 15.03/ANZUP International Multicenter Phase II Trial of Focal Ablative STereotactic RAdiotherapy for Cancers of the Kidney (FASTRACK II).

M. Sidhom, T. Kron, F. Foroudi, 2023, International journal of radiation oncology, biology, physics.